01 8VIIV HLTHCARE
01 89242986
01 8Y
01 8Y
01 82029-12-08
Patent Expiration Date : 2029-12-08
DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE
US Patent Number : 9242986
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210192
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-08
Patent Expiration Date : 2029-12-08
US Patent Number : 9242986
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204790
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-08
Patent Expiration Date : 2029-12-08
ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE
US Patent Number : 9242986
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 205551
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-08
Patent Expiration Date : 2029-12-08
ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE
US Patent Number : 9242986
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 215413
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-08
Patent Expiration Date : 2029-12-08
US Patent Number : 9242986
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 213983
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-08
Patent Expiration Date : 2029-12-08
US Patent Number : 9242986
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204790
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-08
Patent Expiration Date : 2029-12-08
US Patent Number : 9242986
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204790
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-08
Patent Expiration Date : 2029-12-08
DOLUTEGRAVIR SODIUM; LAMIVUDINE
US Patent Number : 9242986
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 211994
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-08
